We're sorry, but your browser is no longer supported.

To improve your experience on our site and ensure your security, please upgrade to a modern browser Google Chrome, Mozilla Firefox or Microsoft Edge.

For more information click here.

PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023